Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 9 months ago

THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients

Theranexus Synerlab Miglustat Niemann-Pick Type C Disease EMA Approval
BRIEF

published on 09/26/2024 at 18:05, 1 year 10 months ago

Theranexus annonce ses résultats financiers du premier semestre 2024

Résultats Financiers Biopharmaceutique Réduction Des Coûts Theranexus Batten-1
BRIEF

published on 09/26/2024 at 18:05, 1 year 10 months ago

Theranexus announces its financial results for the first half of 2024

Financial Results Cost Reduction Biopharmaceutical Theranexus Batten-1
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 10 months ago

THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2024
Theranexus, société biopharmaceutique, annonce ses résultats semestriels 2024. Baisse significative des charges d'exploitation grâce à la fin d'essais cliniques et efforts de réduction des coûts

Résultats Semestriels Biopharmaceutique Réduction Des Coûts Theranexus Maladies Neurologiques
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 10 months ago

THERANEXUS ANNOUNCES FIRST HALF 2024 FINANCIAL RESULTS
Theranexus reports cost reduction success and positive first half 2024 financial results, led by completion of Batten-1 clinical trial and operating grants

Financial Results Cost Reduction Clinical Trial Theranexus Batten-1
BRIEF

published on 07/11/2024 at 18:50, 2 years ago

Theranexus annonce sa trésorerie au 30 juin 2024 et détaille le progrès de Batten-1

Financement Trésorerie Theranexus Batten-1 Maladie Neurologique
BRIEF

published on 07/11/2024 at 18:50, 2 years ago

Theranexus announces its cash flow as of June 30, 2024 and details the progress of Batten-1

Treasury Funding Theranexus Batten-1 Neurological Disease
PRESS RELEASE

published on 07/11/2024 at 18:45, 2 years ago

Theranexus publie sa trésorerie au 30 juin 2024 et fait le point sur l'avancement de Batten-1
Theranexus publie sa trésorerie au 30 juin 2024, avance sur Batten-1 et ouvre nouvelle ligne de financement en fonds propres. Commercialisation phase 3 Batten-1 en vue

Financement Trésorerie Fonds Propres Theranexus Batten-1
PRESS RELEASE

published on 07/11/2024 at 18:45, 2 years ago

Theranexus publishes its cash position as of 30 June 2024 and presents an update on the progress of Batten-1
Biopharmaceutical company Theranexus announces implementation of new equity line to finance Phase III trial for Batten-1 drug in juvenile Batten disease. Update on Batten-1 program included

Biopharmaceutical Company Phase III Trial Theranexus Batten-1 Equity Line
BRIEF

published on 07/03/2024 at 07:35, 2 years 1 month ago

Theranexus, CRNL et CERMEP lauréats du projet "Pacte de recherche 2024" d'Auvergne-Rhône-Alpes

Recherche Auvergne-Rhône-Alpes Theranexus Neurologie Neuroimagerie

Accesswire

Published on 08/08/2026 at 00:00, 11 hours 11 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 11 hours 56 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 12 hours 11 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 12 hours 41 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 12 hours 56 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 11 hours 50 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 15 hours 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 15 hours 56 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 17 hours 1 minute ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 17 hours 11 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 16 hours 17 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 16 hours 17 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 16 hours 31 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 16 hours 31 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 17 hours 11 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE